Evaluation of recurrent and recalcitrant warts in a deaf adolescent male reveals GATA2 deficiency

Dieu T Doan; Paige V Strebeck; Andrew D Tran; Jason E Farrar; Lauren E Appell; Arunkumar J Modi; Akilah A Jefferson

doi:10.1016/j.jacig.2024.100313

Evaluation of recurrent and recalcitrant warts in a deaf adolescent male reveals GATA2 deficiency

J Allergy Clin Immunol Glob. 2024 Jul 26;3(4):100313. doi: 10.1016/j.jacig.2024.100313. eCollection 2024 Nov.

Authors

Dieu T Doan¹, Paige V Strebeck², Andrew D Tran², Jason E Farrar², Lauren E Appell², Arunkumar J Modi², Akilah A Jefferson¹

Affiliations

¹ Division of Allergy and Immunology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.
² Division of Hematology and Oncology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.

Abstract

Prompt evaluation and genetic testing of patients who present with recurrent and recalcitrant warts, before onset of severe infection or myelodysplastic syndrome, leads to improved outcomes in patients with GATA2 deficiency.

Keywords: GATA2; GATA2 deficiency; Immunodeficiency; bone marrow transplant; cutaneous warts; inborn error of immunity; warts.

Publication types

Case Reports